US Broker Ratings

Corcept Therapeutics (CORT) Stock Analysis: A Promising 10.12% Upside in Biotech

Corcept Therapeutics Incorporated (NASDAQ: CORT) emerges as a compelling player in the biotechnology sector, currently commanding a market capitalization of $8.58 billion. Specializing in the development of therapies for severe..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 14.82% Upside Potential Amid Growing Revenue

Align Technology, Inc. (NASDAQ: ALGN) stands out in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $13.04 billion, the company is a..

Dr. Reddy’s Laboratories Ltd (RDY): Analyst Consensus and Growth Potential Amidst Market Volatility

In the ever-evolving landscape of the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player, offering a diverse range of products across global markets. With a..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 106% Upside Potential in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is a burgeoning player in the biotechnology industry, with a strategic focus on developing innovative cell therapies to combat oncology and other serious diseases. Headquartered..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Unlocking a 20% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a renowned name in the healthcare sector, stands prominently in the medical instruments and supplies industry. With a market capitalization of $5.3 billion, this..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 17.12% Potential Upside with Solid Dividend Yield

Investors with a keen eye on the healthcare sector may find AbbVie Inc. (NYSE: ABBV) an intriguing option, as this pharma giant continues to showcase robust growth prospects and a..

Chemed Corp (CHE) Stock Analysis: Evaluating Its Potential Upside for Healthcare Investors

Chemed Corp (NYSE: CHE) operates in the healthcare sector, specifically within the medical care facilities industry, and has carved out a unique position through its two primary business segments: VITAS..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Unpacking Its 36.62% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology industry, is capturing the attention of investors with its robust pipeline and promising growth prospects. With a market capitalization..

Bruker Corporation (BRKR) Stock Analysis: Navigating Promising Terrain in Healthcare with Caution Due to Valuation Concerns

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specializes in the medical devices industry. With a market capitalization of $8.71 billion, Bruker is a significant entity within..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 111.79% Potential Upside for Savvy Investors

Investors eyeing the biotechnology sector might find ADMA Biologics Inc (NASDAQ: ADMA) an intriguing prospect. With its current market capitalization sitting at an impressive $1.93 billion, ADMA is a notable..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Gem with a 34% Upside Potential

Investors keeping a keen eye on the biotechnology sector may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing opportunity. With a current market cap of $11.66 billion, this biopharmaceutical company..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Healthcare Heavyweight with a 5.16% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a formidable player in the healthcare sector, with a specialized focus on medical devices. With a market capitalization of $7.56 billion, Bio-Rad has carved..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 27% Upside Potential with Robust Growth Metrics

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is capturing the attention of investors with its promising upside potential and impressive growth metrics. As a key player in the..

West Pharmaceutical Services, Inc. (WST): Strong Buy Ratings and 9.4% Potential Upside Signal Promising Investment Outlook

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $23.17 billion,..

Biogen Inc. (BIIB) Investor Outlook: Evaluating the Potential 12% Upside with Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB) stands as a significant player in the healthcare sector, particularly in the drug manufacturing industry. With a market capitalization of $29.02 billion, Biogen has carved a..

Viatris Inc. (VTRS) Investor Outlook: Is the 15.89% Potential Upside Worth the Risk?

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is catching the eyes of investors with a 15.89% potential upside, according to recent analyst ratings. This global pharmaceutical..

HealthEquity, Inc. (HQY) Investor Outlook: Analyzing a 35.62% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands as a prominent player in the health information services industry, offering a robust platform of technology-enabled services for consumers and employers across the United States...

Charles River Laboratories Inte (CRL): Investor Outlook Reveals 16.4% Potential Upside Amidst Robust Buy Ratings

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Its 4.49% Potential Upside for Savvy Investors

Amgen Inc. (NASDAQ: AMGN) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a substantial market capitalization of $182.21 billion, Amgen’s footprint in..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a Potential 37% Upside in the Medical Device Sector

For investors with a keen interest in the healthcare sector, Globus Medical, Inc. (NYSE: GMED) offers a compelling opportunity within the medical device industry. Headquartered in Audubon, Pennsylvania, Globus Medical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds